ArticleClinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis
Cost-Consequence Analysis of Apixaban Versus Rivaroxaban for Managing Patients with Venous Thromboembolism in Saudi Arabia.
Abdulaali R Almutairi et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.